Trialect

Active

Radiology Program: Imaging, CT, MRI, and Clinical Trials

University of Bologna, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amador", Department of Advanced Procedures and Technologies, Radiology Unit

The Radiology Fellowship provides comprehensive training in advanced imaging techniques, including CT, MRI, ultrasound, and Whole Body MRI (WB-MRI). The program focuses on diagnostic imaging in oncology, radiological research methodologies, and clinical trial imaging protocols. Participants will gain hands-on experience with state-of-the-art radiological technologies, RIS-PACS systems, and EPR-integrated diagnostics, ensuring seamless clinical workflow and enhanced patient care.

The fellowship is led by Dr. Alice Rossi, Head of the Radiology Unit, an expert in oncologic imaging with specialized training in Whole Body MRI, radiomic MRI, and multimodal imaging for cancer diagnostics and monitoring. Fellows will actively participate in multidisciplinary oncology groups, contributing to imaging-based decision-making and research initiatives.

Dr. Alice Rossi, MD, PhD

Director, Radiology Unit, IRST
Specialist in CT, MRI, ultrasound, and oncologic imaging
Fellowship experience at European Institute of Oncology (IEO), Milan, and Royal Marsden Hospital, London
Research focus: Whole Body MRI and radiomic MRI studies in oncologic imaging
Published over 30 scientific articles in advanced imaging and oncology diagnostics
Active member of SIRM (Italian Society of Radiology) and ESR (European Society of Radiology)
Contributor to MRI education programs and clinical trial imaging protocols

Main Areas of Interest

📌 Oncologic Imaging – Multimodal imaging techniques in cancer diagnostics
📌 Abdominal CT & Chest CT – High-resolution imaging for oncology and staging
📌 Abdominal MRI – Advanced MRI techniques for liver, pancreas, and GI tumors
📌 Neuro Imaging (Brain Tumors) – Functional imaging and tumor characterization
📌 Whole Body MRI – Comprehensive imaging for hematologic and metastatic diseases
📌 Clinical Trial Imaging – Standardized imaging for research and radiomics

Specialties

Radiology

Techniques You Will Learn

Tumor Staging in Solid and Hematologic Malignancies
✔ Therapy Response Evaluation Using RECIST 1.1
✔ Modern MRI Approaches in Treatment Response Assessment
✔ Identifying Disease Progression, Stability, and Response Patterns
✔ Recognition of Therapy-Related Adverse Reactions on CT

Curriculum

Fellowship Curriculum (4 Weeks, Customizable)

During this four-week observational fellowship/ traineeship, participants will gain hands-on exposure to different imaging modalities following a structured daily schedule. The program can be customized based on the participant’s area of interest.

Week 1: Observational Learning
📍 Monday: CT Imaging
📍 Tuesday: CT Imaging
📍 Wednesday: Neuro MRI
📍 Thursday: Body MRI
📍 Friday: Body MRI

Week 2: Observational Learning
📍 Monday: CT Imaging
📍 Tuesday: CT Imaging
📍 Wednesday: Neuro MRI
📍 Thursday: Body MRI
📍 Friday: Body MRI

Week 3: Observational Learning
📍 Monday: Whole Body MRI
📍 Tuesday: Body MRI
📍 Wednesday: Neuro MRI
📍 Thursday: CT Imaging
📍 Friday: CT Imaging

Week 4: Observational Learning
📍 Monday: Whole Body MRI
📍 Tuesday: Body MRI
📍 Wednesday: Neuro MRI
📍 Thursday: CT Imaging
📍 Friday: CT Imaging

FELLOWSHIP HIGHLIGHTS

⭐ Personalized Training & Mentorship – One-on-one guidance from expert radiologists based on the participant's area of interest (CT, MRI, neuroimaging)
⭐ Extensive Hands-On Training – Exposure to oncologic imaging across different modalities
⭐ Participation in Cutting-Edge Research & Clinical Trials – Imaging standardization and radiomics in cancer research
⭐ Opportunity to Join Multidisciplinary Groups – Collaboration with oncologists, radiologists, and clinical researchers
⭐ Networking with Leading Imaging Professionals – Connect with peers and mentors in the radiology field
⭐ Insights into Advanced Imaging Techniques – Learn modern methodologies for cancer staging and therapy response assessment

Accommodation

airbnb.com

Trainees can stay at an accommodation facility (San Giuseppe) located a few hundred meters from our Institute (https://www.irst.emr.it/it/residenza-pazienti).

Fees and Program Logistics

This program has the following durations available:

Duration	Fee
2 weeks	$875.00
4 weeks	$1,500.00

Who Can Apply

none

Host Details

Host Name: Alice Rossi

Affiliation: University of Bologna, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amador", Department of Advanced Procedures and Technologies, Radiology Unit

Address: Via Piero Maroncelli, 40, 47014 Meldola FC, Italy

Website URL: https://www.irst.emr.it/en/home

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.